C4 Therapeutics, Inc. (CCCC)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-18 | Adams Kendra | officer | F | 2,775 | 3.39 | $9,407 |
| 2026-09-18 | Adams Kendra | officer | M | 6,250 | 0 | $0 |
| 2026-07-10 | REYNO LEONARD | officer | F | 7,397 | 4.06 | $30,032 |
| 2026-07-10 | REYNO LEONARD | officer | M | 15,325 | 0 | $0 |
| 2026-07-01 | GROGAN DONNA ROY | director | A | 3,341 | 4.34 | $14,500 |
| 2026-07-01 | Anderson Kenneth Carl | director | A | 2,650 | 4.34 | $11,501 |
| 2026-06-01 | Anderson Kenneth Carl | director | M | 1,070 | 2.11 | $2,258 |
| 2026-06-01 | Anderson Kenneth Carl | director | M | 1,070 | 2.11 | $2,258 |
| 2026-04-01 | GROGAN DONNA ROY | director | A | 5,370 | 2.7 | $14,499 |
| 2026-04-01 | Anderson Kenneth Carl | director | A | 4,259 | 2.7 | $11,499 |
| 2026-04-01 | Anderson Kenneth Carl | director | A | 4,259 | 2.7 | $11,499 |
| 2026-04-01 | GROGAN DONNA ROY | director | A | 5,370 | 2.7 | $14,499 |
| 2026-02-15 | Hirsch Andrew | director | F | 9,057 | 1.89 | $17,118 |
| 2026-02-15 | Hirsch Andrew | director | M | 20,400 | 0 | $0 |
| 2026-02-15 | Hirsch Andrew | director | F | 9,057 | 1.89 | $17,118 |
| 2026-02-15 | Hirsch Andrew | director | M | 20,400 | 0 | $0 |
| 2026-02-14 | Mossler Mark | officer | F | 3,268 | 1.89 | $6,177 |
| 2026-02-14 | Mossler Mark | officer | M | 9,420 | 0 | $0 |
| 2026-02-14 | Adams Kendra | officer | F | 15,381 | 1.89 | $29,070 |
| 2026-02-14 | Adams Kendra | officer | M | 30,950 | 0 | $0 |
| 2026-02-14 | REYNO LEONARD | officer | F | 16,579 | 1.89 | $31,334 |
| 2026-02-14 | REYNO LEONARD | officer | M | 30,950 | 0 | $0 |
| 2026-02-14 | Hirsch Andrew | director | F | 39,154 | 1.89 | $74,001 |
| 2026-02-14 | Hirsch Andrew | director | M | 81,725 | 0 | $0 |
| 2026-02-14 | Schick Kelly | officer | F | 7,269 | 1.89 | $13,738 |
| 2026-02-14 | Schick Kelly | officer | M | 20,950 | 0 | $0 |
| 2026-02-14 | Mahaney Paige | officer | F | 2,446 | 1.89 | $4,623 |
| 2026-02-14 | Mahaney Paige | officer | M | 7,050 | 0 | $0 |
| 2026-02-14 | Boyle Scott N | officer | F | 7,269 | 1.89 | $13,738 |
| 2026-02-14 | Boyle Scott N | officer | M | 20,950 | 0 | $0 |
| 2026-02-14 | Boyle Scott N | officer | F | 7,269 | 1.89 | $13,738 |
| 2026-02-14 | Boyle Scott N | officer | M | 20,950 | 0 | $0 |
| 2026-02-14 | Mahaney Paige | officer | M | 7,050 | 0 | $0 |
| 2026-02-14 | Mahaney Paige | officer | F | 2,446 | 1.89 | $4,623 |
| 2026-02-14 | Schick Kelly | officer | M | 20,950 | 0 | $0 |
| 2026-02-14 | Schick Kelly | officer | F | 7,269 | 1.89 | $13,738 |
| 2026-02-14 | Hirsch Andrew | director | F | 39,154 | 1.89 | $74,001 |
| 2026-02-14 | Hirsch Andrew | director | M | 81,725 | 0 | $0 |
| 2026-02-14 | REYNO LEONARD | officer | F | 16,579 | 1.89 | $31,334 |
| 2026-02-14 | REYNO LEONARD | officer | M | 30,950 | 0 | $0 |
| 2026-02-14 | Adams Kendra | officer | F | 15,381 | 1.89 | $29,070 |
| 2026-02-14 | Adams Kendra | officer | M | 30,950 | 0 | $0 |
| 2026-02-14 | Mossler Mark | officer | M | 9,420 | 0 | $0 |
| 2026-02-14 | Mossler Mark | officer | F | 3,268 | 1.89 | $6,177 |
| 2026-02-13 | Mossler Mark | officer | A | 56,980 | 0 | $0 |
| 2026-02-13 | Adams Kendra | officer | F | 1,863 | 1.89 | $3,521 |
| 2026-02-13 | Adams Kendra | officer | M | 3,750 | 0 | $0 |
| 2026-02-13 | Adams Kendra | officer | A | 240,000 | 0 | $0 |
| 2026-02-13 | REYNO LEONARD | officer | A | 240,000 | 0 | $0 |
| 2026-02-13 | Hirsch Andrew | director | A | 700,000 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-21 4
- 2026-08-14 144
- 2026-08-14 144
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-13 144
- 2026-08-12 144
- 2026-08-12 SCHEDULE 13G/A
- 2026-08-11 10-Q
- 2026-08-11 8-K
- 2026-07-13 4
- 2026-07-02 4
- 2026-07-02 4
- 2026-06-26 4
- 2026-06-26 4
- 2026-06-26 4
- 2026-06-26 4
- 2026-06-26 4
- 2026-06-26 4